169 related articles for article (PubMed ID: 36430553)
1. Limitations of Tamoxifen Application for In Vivo Genome Editing Using Cre/ER
Ilchuk LA; Stavskaya NI; Varlamova EA; Khamidullina AI; Tatarskiy VV; Mogila VA; Kolbutova KB; Bogdan SA; Sheremetov AM; Baulin AN; Filatova IA; Silaeva YY; Filatov MA; Bruter AV
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430553
[TBL] [Abstract][Full Text] [Related]
2. Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases.
Indra AK; Warot X; Brocard J; Bornert JM; Xiao JH; Chambon P; Metzger D
Nucleic Acids Res; 1999 Nov; 27(22):4324-7. PubMed ID: 10536138
[TBL] [Abstract][Full Text] [Related]
3. SPC-Cre-ERT2 transgenic mouse for temporal gene deletion in alveolar epithelial cells.
Gui YS; Wang L; Tian X; Feng R; Ma A; Cai B; Zhang H; Xu KF
PLoS One; 2012; 7(9):e46076. PubMed ID: 23049940
[TBL] [Abstract][Full Text] [Related]
4. Inducible Cre/loxP recombination in the mouse proximal tubule.
Dworniczak B; Skryabin B; Tchinda J; Heuck S; Seesing FJ; Metzger D; Chambon P; Horst J; Pennekamp P
Nephron Exp Nephrol; 2007; 106(1):e11-20. PubMed ID: 17356303
[TBL] [Abstract][Full Text] [Related]
5. Spontaneous recombinase activity of Cre-ERT2 in vivo.
Kristianto J; Johnson MG; Zastrow RK; Radcliff AB; Blank RD
Transgenic Res; 2017 Jun; 26(3):411-417. PubMed ID: 28409408
[TBL] [Abstract][Full Text] [Related]
6. Tetracycline response element driven Cre causes ectopic recombinase activity independent of transactivator element.
Lewis KT; Oles LR; MacDougald OA
Mol Metab; 2022 Jul; 61():101501. PubMed ID: 35452876
[TBL] [Abstract][Full Text] [Related]
7. Podocyte-specific expression of tamoxifen-inducible Cre recombinase in mice.
Yokoi H; Kasahara M; Mukoyama M; Mori K; Kuwahara K; Fujikura J; Arai Y; Saito Y; Ogawa Y; Kuwabara T; Sugawara A; Nakao K
Nephrol Dial Transplant; 2010 Jul; 25(7):2120-4. PubMed ID: 20150167
[TBL] [Abstract][Full Text] [Related]
8. 4-hydroxytamoxifen does not deteriorate cardiac function in cardiomyocyte-specific MerCreMer transgenic mice.
Heinen A; Gödecke S; Flögel U; Miklos D; Bottermann K; Spychala A; Gödecke A
Basic Res Cardiol; 2021 Feb; 116(1):8. PubMed ID: 33544211
[TBL] [Abstract][Full Text] [Related]
9. Tamoxifen administration routes and dosage for inducible Cre-mediated gene disruption in mouse hearts.
Andersson KB; Winer LH; Mørk HK; Molkentin JD; Jaisser F
Transgenic Res; 2010 Aug; 19(4):715-25. PubMed ID: 19894134
[TBL] [Abstract][Full Text] [Related]
10. Expression of tamoxifen-inducible CRE recombinase in Lcn5-CreER
Xu J; Yao G; Ru Y; Xie S
Mol Reprod Dev; 2017 Mar; 84(3):257-264. PubMed ID: 28029195
[TBL] [Abstract][Full Text] [Related]
11. A mouse model with tamoxifen-inducible thyrocyte-specific cre recombinase activity.
Undeutsch H; Löf C; Offermanns S; Kero J
Genesis; 2014 Apr; 52(4):333-40. PubMed ID: 24395757
[TBL] [Abstract][Full Text] [Related]
12. F9 embryonal carcinoma cells engineered for tamoxifen-dependent Cre-mediated site-directed mutagenesis and doxycycline-inducible gene expression.
Chiba H; Chambon P; Metzger D
Exp Cell Res; 2000 Nov; 260(2):334-9. PubMed ID: 11035928
[TBL] [Abstract][Full Text] [Related]
13. Transgenic mice for a tamoxifen-induced, conditional expression of the Cre recombinase in osteoclasts.
Sanchez-Fernandez MA; Sbacchi S; Correa-Tapia M; Naumann R; Klemm J; Chambon P; Al-Robaiy S; Blessing M; Hoflack B
PLoS One; 2012; 7(5):e37592. PubMed ID: 22624050
[TBL] [Abstract][Full Text] [Related]
14. Site- and time-specific gene targeting in the mouse.
Metzger D; Chambon P
Methods; 2001 May; 24(1):71-80. PubMed ID: 11327805
[TBL] [Abstract][Full Text] [Related]
15. The generation and characterization of novel Col1a1FRT-Cre-ER-T2-FRT and Col1a1FRT-STOP-FRT-Cre-ER-T2 mice for sequential mutagenesis.
Zhang M; Kirsch DG
Dis Model Mech; 2015 Sep; 8(9):1155-66. PubMed ID: 26183214
[TBL] [Abstract][Full Text] [Related]
16. Ligand-dependent genetic recombination in fibroblasts : a potentially powerful technique for investigating gene function in fibrosis.
Zheng B; Zhang Z; Black CM; de Crombrugghe B; Denton CP
Am J Pathol; 2002 May; 160(5):1609-17. PubMed ID: 12000713
[TBL] [Abstract][Full Text] [Related]
17. iSuRe-Cre is a genetic tool to reliably induce and report Cre-dependent genetic modifications.
Fernández-Chacón M; Casquero-García V; Luo W; Francesca Lunella F; Ferreira Rocha S; Del Olmo-Cabrera S; Benedito R
Nat Commun; 2019 May; 10(1):2262. PubMed ID: 31118412
[TBL] [Abstract][Full Text] [Related]
18. Generating conditional knockout mice.
Friedel RH; Wurst W; Wefers B; Kühn R
Methods Mol Biol; 2011; 693():205-31. PubMed ID: 21080282
[TBL] [Abstract][Full Text] [Related]
19. Temporal control of gene deletion in sensory ganglia using a tamoxifen-inducible Advillin-Cre-ERT2 recombinase mouse.
Lau J; Minett MS; Zhao J; Dennehy U; Wang F; Wood JN; Bogdanov YD
Mol Pain; 2011 Dec; 7():100. PubMed ID: 22188729
[TBL] [Abstract][Full Text] [Related]
20. Cell type-specific conditional regulation of the c-myc proto-oncogene by combining Cre/loxP recombination and tamoxifen-mediated activation.
Jäger R; Maurer J; Jacob A; Schorle H
Genesis; 2004 Mar; 38(3):145-50. PubMed ID: 15048812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
